A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE study
-
Published:2022-12
Issue:
Volume:54
Page:101767
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Liu GuochenORCID,
Feng Yanling,
Li Jing,
Deng Ting,
Yin Aijun,
Yan Lei,
Zheng Min,
Xiong Ying,
Li Jundong,
Huang Yongwen,
Zhang Chuyao,
Huang He,
Wan Ting,
Huang Qidan,
Lin An,
Jiang Jie,
Kong Beihua,
Liu JihongORCID
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献